From Genetic Tests to Tailored Care: Decoding a field with big potential -- and even bigger implications
By Kelly Bothum,
Delaware Online
| 06. 01. 2010
[Quotes CGS's Jesse Reynolds]
Imagine a doctor using your genetic profile to decide which medicine to prescribe or to determine your risk for developing a life-threatening health problem. It's not a medical fantasy -- genetic tests already are used to gauge how patients will respond to certain drugs or to look for mutations in specific genes that can increase the risk for developing aggressive types of cancer.
But while the potential of so-called personalized medicine seems immense, some big questions are years away from being fully answered. Right now, researchers are still trying to understand key issues related to this next frontier of modern medicine, including how genetic profiling can help patients better understand their health risks, how medical professionals will be able to interpret results and what, if any, ethical implications arise in having this much genetic information.
"Personalized medicine is still in its infancy," said Dr. Ayyappan Rajasekaran, director of the Nemours Center for Childhood Cancer Research, which is studying biomarkers that can help identify more aggressive forms of the disease in kids. "We have a chance to do fantastic work."
At...
Related Articles
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...
By Hannah Devlin, The Guardian | 12.06.2025
Couples undergoing IVF in the UK are exploiting an apparent legal loophole to rank their embryos based on genetic predictions of IQ, height and health, the Guardian has learned.
The controversial screening technique, which scores embryos based on their DNA...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...
